As described previously, IVT-mRNA enables transient CAR expression, mitigating risks of genomic integration and prolonged immune activation (160)
Cignas medical cost ratio, which is the percentage of premium revenue that goes toward medical costs, rose to 84.5% for the second quarter of this year compared to 83.2% for the second quarter of 2025, primarily reflecting higher prior year risk adjustment benefits within our individual and family plans business recognized in second quarter 2025, Cigna said in its second quarter earnings report
Are bananas good for gut health
Optical Buy one complete pair of prescription eyewear and get 40% off other pairs with Plus
The drug is not on the FDA Drug Shortage list, which is what authorized compounded semaglutide and tirzepatide during the 2023-2025 shortages
Neurological disorders Public health challenges